FGF8 and Miyoshi myopathy: Importantly, FGF2 and FGF8, two principal ligands for FGFR3, potently enhanced PLCγ phosphorylation and downstream signaling in MM cells, showing that FGFR3-mediated PLCγ activation is operable in MM cells [219].